Health
Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack – News-Medical.Net
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to…
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme(ACE)inhibitor proven effective in improving survival following heart attacks. Findings from the PARADISE-MI trial were presented at the American College of Cardiologys 70thAnnual Scientific Session.
The study is the first large trial to examine whether sacubitril/valsartan can reduce heart failure…
-
Business13 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General21 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business15 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General12 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips